Krystal Biotech Non-Current Portion of LTD and Capital Lease Obligation (Quarterly) Analysis

Krystal Biotech, Inc. (KRYS)

302.68 +3.23 (+1.08%) USD | NASDAQ | May 26, 16:00

300.00 -2.68 (-0.89%) After-Hours: 20:00

View Non-Current Portion of LTD and Capital Lease Obligation (Quarterly) for KRYS.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Non-Current Portion of LTD and Capital Lease Obligation (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Non-Current Portion of LTD and Capital Lease Obligation (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Non-Current Portion of LTD and Capital Lease Obligation (Quarterly) Benchmarks

Start Trial

TG Therapeutics, Inc.	Upgrade
Marker Therapeutics, Inc.	--
Moderna, Inc.	Upgrade
Catalyst Pharmaceuticals, Inc.	Upgrade
Ocugen, Inc.	Upgrade